Acepodia, Inc.
6976
Rank in Stocks
#16375
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering... Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
Share Price
$0.36733773
Last synced: 2026-11-10
Market Cap
$213.26M
Change (1 day)
-2.43%
Change (1 year)
-25.63%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Acepodia, Inc. (6976)
Category
Healthcare
EPS for Acepodia, Inc. (6976)
EPS as of June 2026 TTM: $-0.03
According to Acepodia, Inc.'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.04, a decrease compared to its 2024 EPS of $-0.03.
EPS history for Acepodia, Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -15.00% |
| 2025 | $-0.04 | 56.23% |
| 2024 | $-0.03 | -43.50% |
| 2023 | $-0.05 | -95.33% |
| 2022 | $-1.00 | -64.18% |
| 2021 | $-2.80 | 95.74% |
| 2020 | $-1.43 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -46,158.82% |
US
|
|
| $-7.07 | 20,694.12% |
US
|
|
| $-5.29 | 15,458.82% |
AU
|
|
| $12.88 | -37,982.65% |
BE
|
|
| $21.56 | -63,511.76% |
NL
|
Questions about Acepodia, Inc.'s earnings per share (EPS)
What is Acepodia, Inc.'s earnings per share (EPS)?
Acepodia, Inc.'s earnings per share (EPS) over the last twelve months is $-0.03, as of Jun 2026.
What was Acepodia, Inc.'s earnings per share (EPS) in 2025?
In 2025, Acepodia, Inc.'s earnings per share (EPS) was $-0.04, compared with $-0.03 in 2024.
How has Acepodia, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Acepodia, Inc.'s earnings per share (EPS) was highest in 2024 ($-0.03) and lowest in 2021 ($-2.80).
How does Acepodia, Inc.'s earnings per share (EPS) compare with similar companies?
Acepodia, Inc.'s earnings per share (EPS) ($-0.03) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.